R&D News: New studies support fortification benefits
Kyowa Hakko USA, Ganeden Biotech release studies highlighting ingredient fortification
According to a recent consumer survey by Kyowa Hakko USA Inc., New York, only 16 percent of consumers would give their immune systems an A grade, leaving 84 percent of consumers looking for ways to support their less-than-perfect body defenses. The ingredient manufacturer also shared a new long-term, randomized, double-blind, placebo-controlled human clinical trial that showed, for the first time, that an oral supplement of Setria glutathione can strengthen the body’s immune system. The results of the study, led by John P. Richie of Penn State University and published in the European Journal of Nutrition, showed that supplementation of glutathione doubled natural killer cell activity. In other news, the company announced it has received a patent for the combination of the amino acids L-Citrulline and L-Arginine. The patent protects the use of L-Citrulline and L-Arginine in formulations used to rapidly and effectively increase blood L-Arginine levels.